Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Biomerieux ADR (OTC : BMXXY) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.
Quote
| Last: | $9.07 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $9.07 |
| Close: | $9.07 |
| High: | $9.07 |
| Low: | $9.07 |
| Volume: | 243 |
| Last Trade Date Time: | 06/05/2026 11:34:08 am |
Stock Data
| Market Cap: | $17,221,557,510 |
|---|---|
| Float: | 1,183,612,200 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Country: | FR |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Biomerieux ADR (OTC: BMXXY).
